- Home
- NSIT vs BHVN Comparison
NSIT vs BHVN Comparison
Compare NSIT & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSIT | BHVN |
|---|---|---|
| Founded | 1988 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 1996 | 2022 |
Fundamental Metrics
Financial Performance| Metric | NSIT | BHVN |
|---|---|---|
| Price | $116.69 | $14.39 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 14 |
| Target Price | ★ $116.25 | $29.08 |
| AVG Volume (30 Days) | 428.5K | ★ 3.6M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.08 |
| EPS | ★ 0.97 | N/A |
| Revenue | ★ $8,247,180,000.00 | N/A |
| Revenue This Year | $3.79 | N/A |
| Revenue Next Year | $2.16 | N/A |
| P/E Ratio | $121.52 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $63.62 | $7.48 |
| 52 Week High | $148.36 | $18.57 |
Technical Indicators
Market Signals| Indicator | NSIT | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 55.47 | 49.50 |
| Support Level | $104.13 | $8.25 |
| Resistance Level | $123.69 | $17.01 |
| Average True Range (ATR) | 3.85 | 0.94 |
| MACD | -0.69 | -0.29 |
| Stochastic Oscillator | 51.52 | 21.31 |
Price Performance
Historical ComparisonAbout NSIT Insight Enterprises Inc.
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, government agencies, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital workplace, cloud/data center transformation, IT modernization, Cyber Security and supply chain optimization solutions and services.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.